Physician profile
Amber Elling
NPI 1902459134
$4,051.97
in general payments reported to CMS, 2019-2025
19 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $310 · 2022: $1,055 · 2023: $521 · 2024: $1,804 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,734 · Travel and Lodging: $934 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,733.60 |
| Travel and Lodging | $934.48 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,813.55 | 2022-2024 | Axonics |
| Myovant Sciences INC. | $582.42 | 2021-2022 | |
| Novo Nordisk INC | $411.26 | 2021-2025 | Wegovy, Saxenda |
| Sumitomo Pharma America, INC. | $381.05 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $208.34 | 2024-2025 | Veozah |
| Lilly USA, LLC | $153.27 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Currax Pharmaceuticals LLC | $100.84 | 2021-2025 | Contrave, Nexlizet, Nexletol |
| Abbvie INC. | $79.19 | 2021-2024 | |
| Aspira Women'S Health INC | $75.00 | 2022 | |
| Biogen, INC. | $54.68 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $43.97 | 2022-2023 | |
| Convatec INC. | $33.01 | 2023 | |
| Evofem Biosciences, INC. | $20.64 | 2022 | |
| Millicent US INC | $19.28 | 2025 | Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $18.58 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.45 | 2024 | Cologuard Collection Kit |
| Exeltis, USA INC. | $14.72 | 2023 | Slynd |
| Vivus LLC | $14.03 | 2022 | |
| Sage Therapeutics, LLC | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Elling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.